BOLD Boundless Bio, Inc. - Common Stock
$2,90
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 7, 2026
52W-Spanne
$1–$3
96% of range
Analystenbewertung
HOLD
6 analysts
Kursziel
$4
+38% upside
P/E (TTM)
-1.1
ROE
-46.7%
Nettogewinnmarge
—
Über Boundless Bio, Inc. - Common Stock Unternehmensübersicht von Wikipedia
BOLD Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.90
Marktkapitalisierung
$65M
P/E (TTM)
-1.1
EPS (TTM)
$-2.60
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-46.7%
Verschuldungsgrad
—
52W-Spanne
$1 – $3
BOLD Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-2.60
2023-12-31
→
2025-12-31
Freier Cashflow
$-47M
2024-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
BOLD
Peer-Median
P/E (TTM)
-1.1
—
P/B (K/B)
0.7
1.6
Price / FCF (Kurs / FCF)
-1.4
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
BOLD
Peer-Median
ROA
-32.0%
-64.3%
ROE
-46.7%
-102.1%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
BOLD
Peer-Median
Current Ratio (Liquiditätsgrad)
8.7
4.8
Quick Ratio
8.6
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
BOLD
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
BOLD
Peer-Median
BOLD Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
VERKAUF
6 Analysten
- Starker Kauf 0 0,0%
- Kauf 0 0,0%
- Halten 3 50,0%
- Verkauf 1 16,7%
- Starker Verkauf 2 33,3%
12-Monats-Kursziel
1 Analysten · 2026-08-19
Tief
$4.00
Hoch
$4.00
Median-Ziel
$4.00
+38,2%
Mittelwert-Ziel
$4.00
+38,2%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.07%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-1.06 | $-0.59 | -0.47% |
| 31. März 2026 | $-0.60 | $-0.59 | -0.01% |
| 31. Dezember 2025 | $-0.58 | $-0.53 | -0.05% |
| 30. September 2025 | $-0.62 | $-0.59 | -0.03% |
| 30. Juni 2025 | $-0.70 | $-0.66 | -0.04% |
| 31. März 2025 | $-0.71 | $-0.75 | 0.04% |
| 31. Dezember 2024 | $-0.74 | $-0.78 | 0.04% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| BOLD | $27M | -0.5 | — | — | -46.7% | — |
| XBIT | — | -1.6 | — | — | — | — |
| TENX | $114M | -9.1 | — | — | -52.5% | — |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | — |
| MNOV | $64M | -5.5 | — | -2928.8% | -27.1% | — |
| HRTX | $245M | -10.8 | 7.4% | -13.0% | 312.5% | 73.3% |
| INMB | $41M | -0.8 | 257.1% | -91866.0% | -175.3% | — |
| EXOZ | $92M | -10.0 | — | — | -172.3% | — |
| INKT | — | -3.8 | 4.5% | -6931.8% | 63.4% | — |
| CLNN | $64M | — | -41.5% | -13086.5% | 200.2% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $45M | $55M | $43M | |
| SG&A Expense | $19M | $18M | $12M | |
| Operating Expenses | $64M | $73M | $55M | |
| Operating Income | $-64M | $-73M | $-55M | |
| Interest Income | $5M | $8M | $5M | |
| Other Non-op | $-2.0K | $12.0K | $80.0K | |
| Income Tax | $0 | $0 | · | |
| Net Income | $-58M | $-65M | $-49M | |
| EPS (Basic) | $-2.60 | $-3.85 | $-40.65 | |
| EPS (Diluted) | $-2.60 | $-3.85 | $-40.65 | |
| Shares (Basic) | 22,360,000 | 16,984,000 | 1,216,000 | |
| Shares (Diluted) | 22,360,000 | 16,984,000 | 1,216,000 | |
| EBITDA | $-62M | $-72M | · |
Bilanz 19
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $18M | $27M | $24M | |
| Short-term Investments | $90M | $126M | $97M | |
| Prepaid Expense | $2M | $2M | $3M | |
| Current Assets | $110M | $154M | $124M | |
| PP&E (Net) | $3M | $4M | $3M | |
| PP&E (Gross) | $8M | $8M | $5M | |
| Accum. Depreciation | $5M | $4M | $3M | |
| Total Assets | $157M | $206M | $130M | |
| Accounts Payable | $1M | $1M | $2M | |
| Current Liabilities | $13M | $8M | $9M | |
| Capital Leases | $46M | $48M | · | |
| Total Liabilities | $58M | $56M | $9M | |
| Common Stock | $2.0K | $2.0K | $0 | |
| Paid-in Capital | $358M | $352M | $9M | |
| Retained Earnings | $-260M | $-201M | $-136M | |
| AOCI | $64.0K | $121.0K | $40.0K | |
| Stockholders' Equity | $99M | $151M | $-127M | |
| Liabilities + Equity | $157M | $206M | $130M | |
| Shares Outstanding | 22,407,000 | 22,300,000 | 1,248 |
Cashflow 10
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $1M | $1M | $957.0K | |
| Stock-based Comp | $6M | $8M | $3M | |
| Deferred Tax | $0 | · | · | |
| Other Non-cash | $4M | $-4M | · | |
| Operating Cash Flow | $-47M | $-61M | $-47M | |
| CapEx | $546.0K | $3M | $633.0K | |
| Investing Cash Flow | $38M | $-26M | $-38M | |
| Financing Cash Flow | $141.0K | $90M | $98M | |
| Net Change in Cash | $-9M | $3M | $13M | |
| Free Cash Flow | $-47M | $-63M | · |
Rentabilität 2
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -32.0% | -38.9% | · | |
| ROE | -46.7% | -554.9% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 8.7 | 19.0 | · | |
| Quick Ratio | 8.6 | 18.7 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-58M | $-65M | · | |
| Market Cap | $27M | $64.7K | · | |
| P/E | -0.5 | -0.8 | · | |
| P/B | 0.3 | 0.0 | · | |
| P / Tangible Book | 0.3 | 0.0 | · | |
| P / Cash Flow | -0.6 | -0.0 | · | |
| P / FCF | -0.6 | -0.0 | · | |
| Earnings Yield | -216.7% | -132.8% | · |
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $14M | $10M | $10M | $11M | $12M | $12M | $13M | $14M | $15M | $13M | $10M | |
| SG&A Expense | $10M | $5M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | |
| Operating Expenses | $24M | $14M | $14M | $15M | $17M | $17M | $18M | $19M | $19M | $17M | $14M | |
| Operating Income | $-24M | $-14M | $-14M | $-15M | $-17M | $-17M | $-18M | $-19M | $-19M | $-17M | $-14M | |
| Interest Income | $690.0K | $920.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $2M | |
| Other Non-op | $1.0K | · | $0 | $0 | $0 | $-2.0K | $-85.0K | $32.0K | $33.0K | $32.0K | $64.0K | |
| Net Income | $-24M | $-14M | $-13M | $-14M | $-16M | $-16M | $-16M | $-17M | $-17M | $-15M | $-12M | |
| EPS (Basic) | $-1.06 | $-0.60 | $-0.57 | $-0.62 | $-0.70 | $-0.71 | $9.93 | $-0.74 | $-0.77 | $-12.27 | $-9.75 | |
| EPS (Diluted) | $-1.06 | $-0.60 | $-0.57 | $-0.62 | $-0.70 | $-0.71 | $9.93 | $-0.74 | $-0.77 | $-12.27 | $-9.75 | |
| Shares (Basic) | 22,450,000 | 22,407,000 | -44,682,000 | 22,386,000 | 22,356,000 | 22,300,000 | -28,551,000 | 22,254,000 | 22,023,000 | 1,258,000 | -2,403,000 | |
| Shares (Diluted) | 22,450,000 | 22,407,000 | -44,682,000 | 22,386,000 | 22,356,000 | 22,300,000 | -28,551,000 | 22,254,000 | 22,023,000 | 1,258,000 | -2,403,000 | |
| EBITDA | $-24M | $-14M | · | $-15M | $-17M | $-17M | · | $-19M | $-19M | $-17M | · |
Bilanz 19
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $17M | $18M | $15M | $15M | $15M | $27M | $40M | $31M | $25M | $24M | |
| Short-term Investments | $52M | $75M | $90M | $103M | $112M | $123M | $126M | $127M | $148M | $80M | $97M | |
| Prepaid Expense | $1M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $4M | $7M | $3M | |
| Current Assets | $74M | $95M | $110M | $120M | $130M | $140M | $154M | $170M | $183M | $112M | $124M | |
| PP&E (Net) | $97.0K | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $2M | $3M | |
| PP&E (Gross) | $4M | $8M | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $5M | $5M | |
| Accum. Depreciation | $3M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Total Assets | $74M | $141M | $157M | $169M | $179M | $191M | $206M | $175M | $188M | $117M | $130M | |
| Accounts Payable | $1M | $2M | $1M | $1M | $2M | $1M | $1M | $3M | $2M | $3M | $2M | |
| Current Liabilities | $8M | $10M | $13M | $12M | $9M | $6M | $8M | $10M | $9M | $11M | $9M | |
| Capital Leases | $0 | $45M | $46M | $47M | $48M | $48M | $48M | · | · | · | · | |
| Total Liabilities | $8M | $55M | $58M | $59M | $57M | $55M | $56M | · | · | · | $9M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $0 | $0 | |
| Paid-in Capital | $363M | $360M | $358M | $357M | $356M | $354M | $352M | $350M | $348M | $10M | $9M | |
| Retained Earnings | $-297M | $-273M | $-260M | $-247M | $-233M | $-217M | $-201M | $-185M | $-169M | $-152M | $-136M | |
| AOCI | $-32.0K | $-23.0K | $64.0K | $50.0K | $-4.0K | $32.0K | $121.0K | $236.0K | $-64.0K | $-21.0K | $40.0K | |
| Stockholders' Equity | $66M | $86M | $99M | $110M | $123M | $137M | $151M | $165M | $179M | $-141M | $-127M | |
| Liabilities + Equity | $74M | $141M | $157M | $169M | $179M | $191M | $206M | $175M | $188M | $117M | $130M | |
| Shares Outstanding | 22,475,000 | 22,407,000 | 22,407,000 | 22,386,000 | 22,386,000 | 22,300,000 | 22,300,000 | 22,254,465 | 22,254,102 | 1,262,638 | 1,248 |
Cashflow 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $284.0K | $307.0K | $310.0K | $317.0K | $317.0K | $296.0K | $262.0K | $265.0K | $263.0K | $247.0K | |
| Stock-based Comp | $3M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $911.0K | |
| Other Non-cash | · | $-3M | · | · | · | $-886.0K | · | · | · | · | · | |
| Operating Cash Flow | $-21M | $-15M | $-10M | $-10M | $-12M | $-15M | $-16M | $-13M | $-16M | $-16M | $-12M | |
| CapEx | $38.0K | $8.0K | $424.0K | $15.0K | $48.0K | $59.0K | $466.0K | $483.0K | $2M | $83.0K | $268.0K | |
| Investing Cash Flow | $23M | $15M | $13M | $10M | $11M | $3M | $2M | $22M | $-68M | $18M | $16M | |
| Financing Cash Flow | · | · | $24.0K | $0 | · | · | $113.0K | $-13.0K | $91M | $-924.0K | $-1M | |
| Net Change in Cash | $2M | $-385.0K | $3M | $283.0K | $-420.0K | $-11M | $-14M | $9M | $6M | $1M | $3M | |
| Free Cash Flow | · | $-15M | · | · | · | $-15M | · | · | · | $-16M | · |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -18.7% | -8.2% | · | -8.1% | -8.5% | -10.2% | · | -18.9% | -18.0% | -26.4% | · | |
| ROE | -25.1% | -12.2% | · | -10.1% | -10.4% | 686.3% | · | -20.0% | -18.9% | 21.9% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.5 | 9.9 | · | 10.1 | 14.1 | 22.1 | · | 17.0 | 20.4 | 10.5 | · | |
| Quick Ratio | 9.3 | 9.7 | · | 9.9 | 13.8 | 21.8 | · | 16.7 | 20.0 | 9.9 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-67M | $-59M | · | $-62M | $-65M | $-65M | · | $-62M | $-58M | $-53M | · | |
| Market Cap | $56M | $25M | · | $28M | $23M | $34M | · | $77M | $86M | $18M | · | |
| P/E | -0.8 | -0.4 | · | -0.4 | -0.3 | -0.1 | · | -0.1 | -0.1 | -0.3 | · | |
| P/B | 0.9 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.5 | 0.5 | -0.1 | · | |
| P / Tangible Book | 0.9 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.5 | 0.5 | · | · | |
| P / Cash Flow | · | -1.6 | · | · | · | -2.3 | · | · | · | -1.1 | · | |
| P / FCF | · | -1.6 | · | · | · | -2.3 | · | · | · | -1.1 | · | |
| Earnings Yield | -119.2% | -239.1% | · | -225.2% | -289.1% | -959.6% | · | -705.8% | -879.3% | -302.9% | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Nettoergebnis | $-58M | $-65M | $-49M |
| Verwässerte EPS | $-2.60 | $-3.85 | $-40.65 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Liquiditätsgrad | 8.7 | 19.0 | — |
| Quick Ratio | 8.6 | 18.7 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Freier Cashflow | $-47M | $-63M | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 45 Einreicher · $37.6M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 16 (+12 vs. Vorquartal) | 7 (+1 vs. Vorquartal) | 8 (+2 vs. Vorquartal) | 10 (+2 vs. Vorquartal) | +8.0M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| ARCH Venture Management, LLC | $6.735.238 | 2.694.095 | 17,91% | Aktien |
| TANG CAPITAL MANAGEMENT LLC | $6.399.688 | 2.559.875 | 17,02% | Aktien |
| ADAR1 Capital Management, LLC | $4.920.540 | 1.968.216 | 13,08% | Aktien |
| Nextech Invest Ltd. | $3.561.400 | 1.228.069 | 9,47% | Aktien |
| FMR LLC | $3.332.450 | 1.332.980 | 8,86% | Aktien |
| Cormorant Asset Management, LP | $2.500.000 | 1.000.000 | 6,65% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.537.308 | 614.923 | 4,09% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $1.390.583 | 556.233 | 3,70% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $1.196.598 | 478.639 | 3,18% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.178.925 | 471.570 | 3,13% | Aktien |
| Alyeska Investment Group, L.P. | $750.000 | 300.000 | 1,99% | Aktien |
| Affinity Asset Advisors, LLC | $625.000 | 250.000 | 1,66% | Aktien |
| RBF Capital, LLC | $500.000 | 200.000 | 1,33% | Aktien |
| Ensign Peak Advisors, Inc | $399.588 | 159.835 | 1,06% | Aktien |
| Stonepine Capital Management, LLC | $386.488 | 154.595 | 1,03% | Aktien |
| CITADEL ADVISORS LLC | $362.623 | 145.049 | 0,96% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $320.000 | 128.000 | 0,85% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $240.132 | 96.053 | 0,64% | Aktien |
| PRELUDE CAPITAL MANAGEMENT, LLC | $209.995 | 83.998 | 0,56% | Aktien |
| Rangeley Capital, LLC | $185.000 | 74.000 | 0,49% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $162.840 | 65.136 | 0,43% | Aktien |
| SUPERSTRING CAPITAL MANAGEMENT LP | $138.390 | 55.356 | 0,37% | Aktien |
| JANE STREET GROUP, LLC | $114.675 | 45.870 | 0,30% | Aktien |
| NORTHERN TRUST CORP | $87.060 | 34.824 | 0,23% | Aktien |
| XTX Topco Ltd | $83.403 | 33.361 | 0,22% | Aktien |
| Nuveen Asset Management, LLC | $62.417 | 21.523 | 0,17% | Aktien |
| Qube Research & Technologies Ltd | $50.518 | 20.207 | 0,13% | Aktien |
| China Universal Asset Management Co., Ltd. | $42.250 | 16.900 | 0,11% | Aktien |
| STATE STREET CORP | $39.905 | 15.962 | 0,11% | Aktien |
| MORGAN STANLEY | $32.500 | 13.000 | 0,09% | Aktien |
| Caitong International Asset Management Co., Ltd | $26.108 | 10.443 | 0,07% | Aktien |
| Pure Financial Advisors, LLC | $25.250 | 10.100 | 0,07% | Aktien |
| BlackRock, Inc. | $10.223 | 4.089 | 0,03% | Aktien |
| Tower Research Capital LLC (TRC) | $870 | 348 | 0,00% | Aktien |
| VANGUARD GROUP INC | $515 | 429 | 0,00% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $440 | 176 | 0,00% | Aktien |
| ACADIAN ASSET MANAGEMENT LLC | $365 | 146.757 | 0,00% | Aktien |
| HRT FINANCIAL LP | $290 | 116.288 | 0,00% | Aktien |
| GSA CAPITAL PARTNERS LLP | $181 | 72.353 | 0,00% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $125 | 50 | 0,00% | Aktien |
| JPMORGAN CHASE & CO | $25 | 10 | 0,00% | Aktien |
| CWM, LLC | $9 | 8 | 0,00% | Aktien |
| Financial Management Professionals, Inc. | $5 | 2 | 0,00% | Aktien |
| UBS Group AG | $5 | 2 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $5 | 2 | 0,00% | Aktien |
Unternehmensinsider 14 Insider · 8 Führungskräfte · 7 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Zachary Hornby | President & CEO | 23. Januar 2026 A | — | 0 | 0 | $0 |
| Jami Rubin | Chief Financial Officer | 19. August 2024 A | — | 0 | 0 | $0 |
| Robert Doebele | Chief Medical Officer | 23. Januar 2026 A | — | 0 | 0 | $0 |
| Jessica Oien | Chief Legal Officer and Corporate Secretary | 23. Januar 2026 A | — | 0 | 0 | $0 |
| Christian Hassig | Chief Scientific Officer | 23. Januar 2026 A | — | 0 | 0 | $0 |
| David A Hinkle | Senior VP, Finance, Controller and Treasurer | 23. Januar 2026 A | — | 0 | 0 | $0 |
| Klaus W. Wagner | Chief Medical Officer | 19. August 2024 A | — | 0 | 0 | $0 |
| Neil Abdollahian | Chief Business Officer | 19. August 2024 A | — | 0 | 0 | $0 |
| James Christensen | Direktor | 15. Juni 2026 A | — | 0 | 0 | $0 |
| Nancy Whiting | Direktor | 15. Juni 2026 A | — | 0 | 0 | $0 |
| Jennifer Lew | Direktor | 15. Juni 2026 A | — | 0 | 0 | $0 |
| Jonathan E Lim | Direktor | 15. Juni 2026 A | 550.915 | 0 | 0 | $0 |
| Christine Brennan | Direktor | 23. Juni 2025 A | — | 0 | 0 | $0 |
| Kristina Burow | Direktor | 23. Juni 2025 A | 1.181.766 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., ARCH Venture Fund X Overage, L.P., ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Partners X Overage, L.P., ARCH Venture Partners IX, LLC, ARCH Venture Partners X, LLC, Robert Nelsen, Keith Crandell, Clinton Bybee, Kristina Burow, Steven Gillis | 29. Oktober 2024 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 3 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.